206 related articles for article (PubMed ID: 15704683)
41. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
[TBL] [Abstract][Full Text] [Related]
42. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
[TBL] [Abstract][Full Text] [Related]
43. The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy.
Heracek J; Urban M; Sachova J; Kuncova J; Eis V; Mandys V; Hampl R; Starka L
Neuro Endocrinol Lett; 2007 Feb; 28(1):45-51. PubMed ID: 17277727
[TBL] [Abstract][Full Text] [Related]
44. [Suprapubic transvesical prostatectomy with opening the prostatic cavity wide to treat benign prostatic hyperplasia of small volume].
Zha JZ
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):247-8. PubMed ID: 16597044
[TBL] [Abstract][Full Text] [Related]
45. Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes.
Berg A; Dahl AA; Bruland ØS; Bjøro T; Aanensen MS; Fosså SD
Prostate Cancer Prostatic Dis; 2009; 12(3):269-76. PubMed ID: 19290019
[TBL] [Abstract][Full Text] [Related]
46. [Influence of different operation modes in treatment of leiomyoma on reproductive endocrine hormone levels].
Yang XJ; Li N; Fang XL; Zhu M
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):20-2. PubMed ID: 17403306
[TBL] [Abstract][Full Text] [Related]
47. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
[TBL] [Abstract][Full Text] [Related]
48. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
[TBL] [Abstract][Full Text] [Related]
49. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
[TBL] [Abstract][Full Text] [Related]
50. Developmental changes of plasma inhibin, gonadotropins, steroid hormones, and thyroid hormones in male and female Shao ducks.
Yang P; Medan MS; Watanabe G; Taya K
Gen Comp Endocrinol; 2005 Sep; 143(2):161-7. PubMed ID: 16061074
[TBL] [Abstract][Full Text] [Related]
51. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
52. Serum hormone levels in benign prostatic hyperplasia.
Sköldefors H; Blomstedt B; Carlström K
Scand J Urol Nephrol; 1978; 12(2):111-4. PubMed ID: 80820
[TBL] [Abstract][Full Text] [Related]
53. Plasma levels of testosterone, LH and FSH after prostatic adenomectomy.
Fontana D; Isaia GC; Fasolis G; Tagliabue M; Randone DF
Andrologia; 1980; 12(6):556-8. PubMed ID: 6162405
[TBL] [Abstract][Full Text] [Related]
54. Laparoscopic prostatectomy for benign prostatic hyperplasia--a six-year experience.
Mariano MB; Tefilli MV; Graziottin TM; Morales CM; Goldraich IH
Eur Urol; 2006 Jan; 49(1):127-31; discussion 131-2. PubMed ID: 16314034
[TBL] [Abstract][Full Text] [Related]
55. [Therapeutic efficacy of bipolar plasmakinetic technique compared with transurethral resection on benign prostate hyperplasia].
Wu WJ; Wang XH; Wang HP; Zou WB; Liang XY; Cai ZG; Zhong WW; Zou YF; Yuan DZ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3365-7. PubMed ID: 16409848
[TBL] [Abstract][Full Text] [Related]
56. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
[TBL] [Abstract][Full Text] [Related]
57. Clinical observation on treatment of hyperplasia of mammary gland by Lirukang Granule.
Qian LQ; Pei XH; Xu ZY; Wang C
Chin J Integr Med; 2007 Jun; 13(2):120-4. PubMed ID: 17609910
[TBL] [Abstract][Full Text] [Related]
58. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
[TBL] [Abstract][Full Text] [Related]
59. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and alterations of sex hormones in filling-station workers.
Saadat M; Monzavi N
Fertil Steril; 2008 Jun; 89(6):1777-80. PubMed ID: 17880951
[TBL] [Abstract][Full Text] [Related]
60. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
